Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

Completed · Phase 1

Conditions studied: Adrenal Tumors, Adrenal Malignancies, Abnormal Hormonal Secretions, Electrolytes Abnormalities

In brief

The purpose of this study is to find out if your adrenal glands are normal or abnormal. This can be determined by whether or not your adrenal gland concentrates more of a labeled building block of adrenal hormone, norcholesterol. This labeled material had been used as an investigative diagnostic tool for imaging adrenal glands for many years with success in our hands. This is a diagnostic procedure. CT, MRI and Ultrasound can determine the size and presence or absence of tumor but cannot assess the function of the adrenal glands. To determine hormone concentrations from blood samples would involve more invasive catherization.

Key facts

Study ID

NCT00591643

Run by

Memorial Sloan Kettering Cancer Center

People needed

93

Starts

1977-07-01

Expected to finish

2011-03-01

Last updated by the study team

2015-12-28

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient with clinical and laboratory suspicions of hypersecretion of adrenal cortical hormones

You may not qualify if…

• n/a

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.